Showing results (141-150 of 201) with videos related to
Sort By:
Pageof 21
Neuropathology and Applied Neurobiology|July 28, 2023
A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutantSuzanne Tran, Alice Thomas, Ilyes Aliouat, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trialJaime Gállego Pérez-Larraya, François Ducray, Olivier Chinot, et al.Journal of Neurology|July 6, 2026
Radiological and FDG-PET imaging features of Epstein-Barr virus-positive primary central nervous system lymphomasNina Schulz, Dario Herrán de la Gala, Laura Rozenblum, et al.European Journal of Human Genetics : EJHG|August 13, 2015
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysisBen Kinnersley, Yoichiro Kamatani, Marianne Labussière, et al.Annals of Neurology|May 1, 2007
Dynamic history of low-grade gliomas before and after temozolomide treatmentDamien Ricard, Gentian Kaloshi, Alexandra Amiel-Benouaich, et al.Blood Advances|June 30, 2022
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network studyPaul Lesueur, Gandhi Damaj, Khê Hoang-Xuan, et al.The New England Journal of Medicine|April 13, 2007
Radiotherapy for glioblastoma in the elderlyFlorence Keime-Guibert, Olivier Chinot, Luc Taillandier, et al.European Journal of Endocrinology|February 8, 2024
KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomasFanny Chasseloup, Daniela Regazzo, Lucie Tosca, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type GlioblastomasMaite Verreault, Charlotte Schmitt, Lauriane Goldwirt, et al.Scientific Reports|December 3, 2015
Quantifying the heritability of glioma using genome-wide complex trait analysisBen Kinnersley, Jonathan S Mitchell, Konstantinos Gousias, et al.Pageof 21